LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,416,107
تعداد دریافت فایل اصل مقاله11,291,823
Sadeghi, Abolfazl, Bayazidi, Yahya, Davari, Majid, Kebriaeezadeh, Abbas, Assarian, Amin, Esteghamati, Alireza, Yousefi, Sepideh. (1402). Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis. سامانه مدیریت نشریات علمی, 48(3), 286-291. doi: 10.30476/ijms.2022.92805.2409
Abolfazl Sadeghi; Yahya Bayazidi; Majid Davari; Abbas Kebriaeezadeh; Amin Assarian; Alireza Esteghamati; Sepideh Yousefi. "Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis". سامانه مدیریت نشریات علمی, 48, 3, 1402, 286-291. doi: 10.30476/ijms.2022.92805.2409
Sadeghi, Abolfazl, Bayazidi, Yahya, Davari, Majid, Kebriaeezadeh, Abbas, Assarian, Amin, Esteghamati, Alireza, Yousefi, Sepideh. (1402). 'Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis', سامانه مدیریت نشریات علمی, 48(3), pp. 286-291. doi: 10.30476/ijms.2022.92805.2409
Sadeghi, Abolfazl, Bayazidi, Yahya, Davari, Majid, Kebriaeezadeh, Abbas, Assarian, Amin, Esteghamati, Alireza, Yousefi, Sepideh. Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis. سامانه مدیریت نشریات علمی, 1402; 48(3): 286-291. doi: 10.30476/ijms.2022.92805.2409

Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis

Iranian Journal of Medical Sciences
مقاله 6، دوره 48، شماره 3، مرداد 2023، صفحه 286-291    اصل مقاله (271.54 K)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2022.92805.2409
نویسندگان
Abolfazl Sadeghi1؛ Yahya Bayazidi* 1؛ Majid Davari1؛ Abbas Kebriaeezadeh1؛ Amin Assarian1؛ Alireza Esteghamati2؛ Sepideh Yousefi3
1Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2Endocrinology and Metabolism Research Center, Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3School of Pharmacy and Pharmaceutical Science, Islamic Azad University, Tehran, Iran
چکیده
Background: Clinical guidelines and expert committees have recently suggested that the hemoglobin A1C (HbA1c) should be individualized based on various criteria. Data regarding the achievement of individualized glycemic targets in type 2 diabetes mellitus (T2DM) patients is scant in Iran. We intended to provide information found on real-world outcomes from the perspective of an individualized recommendation.
Methods: A cross-sectional analysis was conducted in 15 diabetes centers in Iran between 2013-2017. Two steps cluster sampling selection was used to recruit 1591 patients with T2DM. Considering Ismail-Beigi’s individualized strategy, the study population was categorized into five treatment intensities of HbA1c: most intensive (≤6.5%), intensive (6.5–7.0%), less intensive (~7.0%), not intensive (7.0–8.0%), and moderated (~8.0%). The percentage of patients who met their group individualized glycemic targets was estimated as the degree of achievement of each treatment intensity.
Results: The cumulative incidence rate of early microvascular, advanced microvascular, and macrovascular complications was 53%, 25%, and 34%, respectively. Besides, 78% [77.6-79%] of patients did not achieve individualized glycemic targets. 
Conclusion: The outcome showed poor individualized glycemic control and a high incidence of diabetes complications. Considering individualized HbA1c targets for Iranian patients with T2DM is an urgent need.  
کلیدواژه‌ها
Diabetes mellitus؛ Individualized glycemic control؛ Precision medicine؛ Diabetes complications
سایر فایل های مرتبط با مقاله
مراجع
  1. Writing Group for the DERG, Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D, et al. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA. 2015;313:45-53. doi: 10.1001/jama.2014.16107. PubMed PMID: 25562265; PubMed Central PMCID: PMCPMC4306335.
  2. Zabala A, Darsalia V, Holzmann MJ, Franzen S, Svensson AM, Eliasson B, et al. Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study. Diabetes Obes Metab. 2020;22:182-90. doi: 10.1111/dom.13885. PubMed PMID: 31576643.
  3. American Diabetes A. Standards of medical care in diabetes--2012. Diabetes Care. 2012;35:S11-63. doi: 10.2337/dc12-s011. PubMed PMID: 22187469; PubMed Central PMCID: PMCPMC3632172.
  4. American Diabetes A. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37:S14-80. doi: 10.2337/dc14-S014. PubMed PMID: 24357209.
  5. American Diabetes A. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41:S55-S64. doi: 10.2337/dc18-S006. PubMed PMID: 29222377.
  6. Kaze AD, Santhanam P, Erqou S, Ahima RS, Echouffo-Tcheugui JB. Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study. BMJ Open Diabetes Res Care. 2020;8. doi: 10.1136/bmjdrc-2020-001753. PubMed PMID: 33257421; PubMed Central PMCID: PMCPMC7705503.
  7. Moradi Y, Baradaran HR, Djalalinia S, Chinekesh A, Khamseh ME, Dastoorpoor M, et al. Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis. Diabetes Metab Syndr. 2019;13:2300-12. doi: 10.1016/j.dsx.2019.05.018. PubMed PMID: 31235172.
  8. Menendez Torre E, Lafita Tejedor FJ, Artola Menendez S, Millan Nunez-Cortes J, Alonso Garcia A, Puig Domingo M, et al. Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes. Aten Primaria. 2011;43:202. doi: 10.1016/j.aprim.2010.07.012. PubMed PMID: 21382648; PubMed Central PMCID: PMCPMC7024946.
  9. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17:1-53. doi: 10.4158/ep.17.s2.1. PubMed PMID: 21474420.
  10. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Spectrum. 2012;25:154-71. doi: 10.2337/diaspect.25.3.154.
  11. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154:554-9. doi: 10.7326/0003-4819-154-8-201104190-00007. PubMed PMID: 21502652.
  12. Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41:2669-701. doi: 10.2337/dci18-0033. PubMed PMID: 30291106; PubMed Central PMCID: PMCPMC6245208.
  13. Laiteerapong N, Cooper JM, Skandari MR, Clarke PM, Winn AN, Naylor RN, et al. Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018;168:170-8. doi: 10.7326/M17-0537. PubMed PMID: 29230472; PubMed Central PMCID: PMCPMC5989575.
  14. Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, Afshin A. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis. PLoS One. 2015;10:e0132505. doi: 10.1371/journal.pone.0132505. PubMed PMID: 26200913; PubMed Central PMCID: PMCPMC4511591.
  15. Peykari N, Djalalinia S, Kasaeian A, Naderimagham S, Hasannia T, Larijani B, et al. Diabetes research in Middle East countries; a scientometrics study from 1990 to 2012. J Res Med Sci. 2015;20:253-62. PubMed PMID: 26109972; PubMed Central PMCID: PMCPMC4468230.
  16. Laiteerapong N, John PM, Nathan AG, Huang ES. Public health implications of recommendations to individualize glycemic targets in adults with diabetes. Diabetes Care. 2013;36:84-9. doi: 10.2337/dc11-2344. PubMed PMID: 22961575; PubMed Central PMCID: PMCPMC3526201.
  17. Coons MJ, Greiver M, Aliarzadeh B, Meaney C, Moineddin R, Williamson T, et al. Is glycemia control in Canadians with diabetes individualized? A cross-sectional observational study. BMJ Open Diabetes Res Care. 2017;5:e000316. doi: 10.1136/bmjdrc-2016-000316. PubMed PMID: 28761645; PubMed Central PMCID: PMCPMC5530242.
  18. Moradi Y, Baradaran HR, Djalalinia S, Chinekesh A, Khamseh ME, Dastoorpoor M, et al. Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis. Diabetes Metab Syndr. 2019;13:2300-12. doi: 10.1016/j.dsx.2019.05.018. PubMed PMID: 31235172.
  19. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-81. doi: 10.1016/j.diabres.2018.02.023. PubMed PMID: 29496507.
  20. Dhanaraj E, Raval AD, Yadav R, Bhansali A, Tiwari P. Prescribing pattern of antidiabetic drugs and achievement of glycemic control in T2DM patients tertiary care hospital in North India. International Journal of Diabetes in Developing Countries. 2013;33:140-6. doi: 10.1007/s13410-013-0123-5.
  21. Lipska KJ, Yao X, Herrin J, McCoy RG, Ross JS, Steinman MA, et al. Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013. Diabetes Care. 2017;40:468-75. doi: 10.2337/dc16-0985. PubMed PMID: 27659408; PubMed Central PMCID: PMCPMC5360291.
  22. Cheng AY, Lau DC. The Canadian Diabetes Association 2013 clinical practice guidelines-raising the bar and setting higher standards! Can J Diabetes. 2013;37:137-8. doi: 10.1016/j.jcjd.2013.04.005. PubMed PMID: 24070834.
  23. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. Diabetes Care. 2012;35:2650-64. doi: 10.2337/dc12-1801. PubMed PMID: 23100048; PubMed Central PMCID: PMCPMC3507610.
  24. Caverly TJ, Fagerlin A, Zikmund-Fisher BJ, Kirsh S, Kullgren JT, Prenovost K, et al. Appropriate Prescribing for Patients With Diabetes at High Risk for Hypoglycemia: National Survey of Veterans Affairs Health Care Professionals. JAMA Intern Med. 2015;175:1994-6. doi: 10.1001/jamainternmed.2015.5950. PubMed PMID: 26502113.
  25. Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015;175:356-62. doi: 10.1001/jamainternmed.2014.7345. PubMed PMID: 25581565; PubMed Central PMCID: PMCPMC4426991.
  26. Shi Min Ko M, Kit Lee W, Chang Ang L, Goh SY, Mong Bee Y, Ming Teh M. A Cross-Sectional study on risk factors for severe hypoglycemia among Insulin-Treated elderly type 2 diabetes Mellitus (T2DM) patients in Singapore. Diabetes Res Clin Pract. 2022;185:109236. doi: 10.1016/j.diabres.2022.109236. PubMed PMID: 35131380.
  27. Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013;36:2271-9. doi: 10.2337/dc12-2258. PubMed PMID: 23418368; PubMed Central PMCID: PMCPMC3714503.
آمار
تعداد مشاهده مقاله: 814
تعداد دریافت فایل اصل مقاله: 486


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب